(Q33926165)

30 July 2017

1 reference

title

Injectable contraception. New and existing options (English)

1 reference

30 July 2017

1 reference

Kaunitz AM

1

1 reference

30 July 2017

1 December 2000

1 reference

Obstetrics and Gynecology Clinics of North America

30 July 2017

1 reference

30 July 2017

27

1 reference

30 July 2017

741-780

1 reference

30 July 2017

4

1 reference

Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The clinical performance of NORPLANT implants over time: a comparison of two cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depot medroxyprogesterone. Management of side-effects commonly associated with its contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The effect of rifampicin on norethisterone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Pharmacokinetic Drug Interactions with Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Uniject as a delivery system for the once-a-month injectable contraceptive Cyclofem in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Forearm bone density in users of Depo-Provera as a contraceptive method

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Risk of contraceptive discontinuation among adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Review of ovulation return upon discontinuation of once-a-month injectable contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Menstrual bleeding patterns in untreated women. Task Force on Long-Acting Systemic Agents for Fertility Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition--an analysis of FSH, oestradiol and inhibin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Estrogen and progestin components of oral contraceptives: relationship to vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

When is it safe to switch from oral contraceptives to hormonal replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

CONCEPTION CONTROL BY MONTHLY INJECTIONS OF MEDROXYPROGESTERONE SUSPENSION AND A LONG-ACTING OESTROGEN

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Laboratory criteria for menopause in women using oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Recovery of bone density in women who stop using medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Spinal bone density in women using depot medroxyprogesterone contraception*1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone density in women receiving depot medroxyprogesterone acetate for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Medroxyprogesterone acetate and homozygous sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A preliminary pharmacological trial of the monthly injectable contraceptive CycloProvera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone density in long term users of depot medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Incidence of ovulation in perimenopausal women before and during hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Effect of contraception on lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation, [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depo-Provera in adolescents: effects of early second injection or prior oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Adolescent satisfaction with postpartum contraception and body weight concerns.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Injectable contraceptives and risk of invasive cervical cancer: evidence of an association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone mineral loss during lactation and recovery after weaning

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Injected Progestogen and Lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Injectable contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Injectable hormones and regulatory controversy: an end to the long-running story?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone mineral changes during pregnancy and lactation: a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Treatment of seizures with medroxyprogesterone acetate: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Smoking and age at menopause in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Hormonal manipulation in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Differential effects on bone density of progestogen-only methods for contraception in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A review of ‘once-a-month's combined injectable contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A comparison of the pharmacokinetic properties of three estradiol esters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone density among long-term users of medroxyprogesterone acetate as a contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

In Utero Exposure to Steroid Contraceptives and Outcome of Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone mineral changes during and after lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Lunelle™ monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Weight change in adolescents who used hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Experiences of injectable contraceptive users in an urban setting

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone mineral density in women using depot medroxyprogesterone acetate for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Spermicides, hormonal contraception and congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Monthly combined injectable contraceptives and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Changes in bone density with lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Factors influencing the age at natural menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depot medroxyprogesterone acetate and osteoporosis. Monitor serum oestradiol concentration in users

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone mineral density in long-term depot medroxyprogesterone acetate acceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Effects of DMPA on weight and blood pressure in long-term acceptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Long-term depot-medroxyprogesterone acetate and bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Contraceptive failure in the United States: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Metabolic effects of depot-medroxyprogesterone acetate in long-term users: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Continuation rates among injectable contraceptive users

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depressive symptoms and Depo-Provera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Depression in users of depo-medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Resea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Deve

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

Estimates of human fertility and pregnancy loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970171-6

7 January 2021

10.1016/S0889-8545(05)70171-6

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11091987